三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
纳武利尤单抗/伊匹单抗联合用药不良反应事件
纳武利尤单抗/伊匹单抗联合用药不良反应事件
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：303KB
图片尺寸：1150*650
同报告图片
/
4
所属报告：
2021年粤开医药行业双抗及免疫细胞激活作用机制梳理分析报告（13页）.pdf
打包全文图表
相关数据
表6各国不良反应监测制度对比
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
收藏
行业数据
2026-03-23
原图定位
查看详情
LBL-024联合化疗一线治疗晚期EP-NEC患者的不良反应情况
收藏
行业数据
2026-02-24
原图定位
查看详情
Amycretin（皮下注射）整体不良反应事件为轻度到中度
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
收藏
行业数据
2025-11-19
原图定位
查看详情
匹米替尼在一期临床试验中对比另外两款CSR-1R抑制剂显示出最佳的安全性，且无任何肝脏相关不良反应
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
收藏
行业数据
2025-10-10
原图定位
查看详情
Remitch中国III期桥验不良反应情
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
收藏
行业数据
2025-08-13
原图定位
查看详情
慢阻肺常用吸入式药物类型、临床应用及不良反应
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
收藏
行业数据
2025-07-30
原图定位
查看详情
ZG005-001项目不良反应（n，%）
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
收藏
行业数据
2025-07-15
原图定位
查看详情
伏美替尼一线治疗不良反应谱（非头对头）
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
收藏
行业数据
2025-07-14
原图定位
查看详情
培莫沙肽及同类药物部分不良反应事件发生率
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
收藏
行业数据
2025-06-09
原图定位
查看详情
芦康沙妥珠、Trodelvy及Datroway的常见不良药物反应发生率
fCBBReexu+WIqyB8IOiLpuWPguaymeWuieeOrzVtZy9rZyAoTj0xODgpIHwgVHJvZGVsdnkgMTBtZy9rZyAoTj0yNTgpIHwgRGF0cm93YXkgNm1nL2tnIChOPTM2MCkgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6KGA5ray55u45YWzQUUgfCA1NCUgfCA3OCUgfCAzMCUgfAp8IOaAp+eykue7huiDnuiuoeaVsOWHj+WwkSB8IDcyJSB8IDk0JSB8IDM1JSB8Cnwg6KGA5bCP5p2/6K6h5pWw5YeP5bCRIHwgMzIlIHwgMjMlIHwgTkEgfAp8IOeZvee7huiDnuiuoeaVsOWHj+WwkSB8IDU5JSB8IDg2JSB8IDQxJSB8Cnwg5reL5be057uG6IOe6K6h5pWw5YeP5bCRIHwgMTglIHwgODglIHwgMzYlIHwKfCDogp3ohI/nm7jlhbNBRSB8IDAlIHwgTkEgfCA0LjIlIHwKfCDogr7ohI/nm7jlhbNBRSB8IDQlIHwgNTklIHwgMTElIHwKfCDohbnms7sgfCA0NCUgfCAxNyUgfCA1OSUgfAp8IOWPo+iFlOeCjiB8IDMxJSB8IDU3JSB8IDU2JSB8Cnwg5oG25b+DIHwgMjclIHwgMzMlIHwgMjQlIHwKfCDlkZXlkJAgfCA1JSB8IDM3JSB8IDM0JSB8Cnwg5L6/56eYIHwgMiUgfCAzMCUgfCAxMSUgfAp8IOWFtuS7lkFFIHwgMzUlIHwgMTIlIHwgMTclIHwKfCDnmq7nlrkgfCAzMiUgfCA0NyUgfCAyMiUgfAp8IOiEseWPkSB8IDE4JSB8IDI4JSB8IDE2JSB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmi5vogqHkuabvvIxEYXRyb3dheeS6p+WTgeivtOaYjuS5pu+8jFRyb2RlbHZ55Lqn5ZOB6K+05piO5Lmm77yM5Lqk6ZO25Zu96ZmF44CC
收藏
行业数据
2025-05-19
原图定位
查看详情
伏美替尼常见不良反应类型及发生频率（发
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
收藏
行业数据
2025-04-25
原图定位
查看详情
表7、各年龄组受试者接种MCV4和对照组疫苗后0-30d局部和全身不良反应发生率
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
收藏
行业数据
2025-04-01
原图定位
查看详情
DPNP治疗药物用法用量及不良反应：克利加巴林有望带来突破
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
收藏
行业数据
2025-03-14
原图定位
查看详情
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似
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
收藏
行业数据
2025-02-17
原图定位
查看详情
奥美克松钠与舒更葡糖钠药物相关不良反应对比
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
收藏
行业数据
2024-12-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
双抗药物免疫细胞激活的机制目标在亍保留联合疗法的疗效，同时建立优亍联合疗法的安全性。研究収现，PD-1 不 CTLA-4 联合疗法癿高毒性可能是由二抗体对肿瘤浸润淋巬细胞（ TIL，Tumor Infiltrating lymphocyte）及外周位点淋巬细胞无巩别癿结合亲和力所致。双抗丌激活外周位点淋巬细胞，仅激活 TIL，有效降低了药物癿 TRAE。如 AK104只能够不共表达 PD-1及 CTLA-4 癿 TIL 四价结合，而不常缺乏检查点共表达丏仅允许事价结合癿外周位点淋巬细胞丌结合，因此可以更好地黏附在 TIL 细胞表面，幵对二在肿瘤微环境中癿淋巬细胞表现出更高癿功能亲和力。
行业数据
原图定位
当前图表所属：
2021年粤开医药行业双抗及免疫细胞激活作用机制梳理分析报告（13页）.pdf
免疫检查点和免疫检查点抑制剂作用机理
NK细胞ADCC作用
双抗聚集/定位T细胞作用机理
MHC-Ⅰ与TCR路径
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2026-03-23
原图定位
微信扫码登录
手机快捷登录
账号登录
